Zealand Pharma A/S (0NZU)

94.55
+2.45(+2.66%)
  • Volume:
    28,004
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    94.55 - 94.55

0NZU Overview

Prev. Close
92.1
Day's Range
94.55-94.55
Revenue
20.78M
Open
91.03
52 wk Range
70.05-212.6
EPS
-
Volume
28,004
Market Cap
4.36B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
50,569
P/E Ratio
-
Beta
-
1-Year Change
-48.7%
Shares Outstanding
46,108,263
Next Earnings Date
10 Aug 2022
What is your sentiment on Zealand Pharma?
or
Market is currently closed. Voting is open during market hours.

Zealand Pharma A/S Company Profile

Zealand Pharma A/S Company Profile

Employees
355
Market
Denmark

Zealand Pharma A/S is a Denmark-based biopharmaceutical company engaged in the discovery, development and commercialization of peptide-based medicines. The Company's pipeline comprises two implementation areas: Cardio-metabolic diseases and Other indications. The Cardio-metabolic diseases area includes medicines for diabetes and obesity treatment, such as Lyxumia (Lixisenatide), Lyxumia/Lantus, ZP2929 and Danegaptide. The Other indications area offers ZP1848, Elsiglutide and ZP1480 (ABT-719) drugs for inflammatory bowel disease, chemotherapy-induced diarrhea and acute kidney injury treatment. Furthermore, the Company collaborates with a number of partners, such as Sanofi, Helsinn, Boehringer Ingelheim, Abbvie and Eli Lilly.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralSell
Technical IndicatorsBuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyBuyStrong Sell